Apex Biotechnology Corp.

Equities

1733

TW0001733004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
35.05 ^TWD	-0.71%		+3.55%	-13.03%

Apr. 30	Apex Biotechnology Corp. Approves Cash Dividend for 2023, Payable on June 14, 2024	CI
Mar. 14	Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Apex Biotechnology Corp.'s Equity Buyback Plan announced on June 6, 2017.

August 01, 2017

From June 5, 2017 to July 6, 2017, the company has repurchased 36,000 shares, representing 0.04% for TWD 1.18 million. With this, the company has completed the repurchase of 36,000 shares, representing 0.04% for TWD 1.18 million under the buyback announced on June 6, 2017.

Latest news about Apex Biotechnology Corp.

Apex Biotechnology Corp. Approves Cash Dividend for 2023, Payable on June 14, 2024	Apr. 30	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 12	CI
Apex Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Apex Biotechnology Corp. Approves Cash Dividend for 2022, Payable on July 13, 2023	23-05-31	CI
Apex Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Apex Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
Apex Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-22	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Apex Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
Apex Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-28	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
Apex Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-11	CI
Apex Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-11	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-24	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-06	CI
Apex Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-12	CI
Apex Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-12	CI
Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-27	CI
Apex Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-11	CI

Chart Apex Biotechnology Corp.

Duration

Period

More charts

Company Profile

APEX BIOTECHNOLOGY CORP is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of testing strips, electrode testing strips and tester suites. The Company primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
APEX BIOTECHNOLOGY CORP.	-13.03%	109M
SHOCKWAVE MEDICAL, INC.	+73.37%	12.41B
PENUMBRA, INC.	-18.59%	8.23B
MASIMO CORPORATION	-0.90%	6.46B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+15.76%	5.5B
GETINGE AB	-4.95%	5.33B
APT MEDICAL INC.	+40.80%	5.1B
ASAHI INTECC CO., LTD.	-17.31%	4.05B
INARI MEDICAL, INC.	-29.79%	2.54B
SHENZHEN YHLO BIOTECH CO., LTD.	+7.56%	1.99B

Medical Equipment

Apex Biotechnology Corp.

Equities

1733

TW0001733004

Medical Equipment, Supplies & Distribution

Tranche Update on Apex Biotechnology Corp.'s Equity Buyback Plan announced on June 6, 2017.

Latest news about Apex Biotechnology Corp.

Chart Apex Biotechnology Corp.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Medical Equipment